Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Bill would authorize studying supervised ibogaine treatment for veterans with PTSD, traumatic brain injury
Summary
A bipartisan group of legislators asked the House committee to authorize supervised clinical study of ibogaine for qualifying veterans with PTSD or traumatic brain injury, citing limited evidence of cognitive and functional gains in small studies.
Representative Alex Carlatos and several senators told the House Committee on Behavioral Health and Health Care on March 13 that House Bill 3817 would authorize supervised clinical use and study of ibogaine, a psychoactive alkaloid derived from a Central African shrub, for qualifying individuals — with a focus on veterans with post‑traumatic stress disorder and traumatic brain injury.
"This bill authorizes the consumption of ibogaine for qualifying individuals within a…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
